JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB275506

Human CCL3 (Macrophage Inflammatory Protein 1) knockout THP-1 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

CCL3 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 61 bp deletion in exon 1.

View Alternative Names

C C motif chemokine 3, CCL3_HUMAN, Chemokine (C C motif) ligand 3, Chemokine C C motif ligand 3, Chemokine ligand 3, G0/G1 switch regulatory protein 19-1, G0S19 1, G0S19 1 protein, Heparin binding chemotaxis protein, L2G25B, LD78 alpha, LD78-alpha(4-69), MIP 1A, MIP-1-alpha, MIP-1-alpha(4-69), Macrophage inflammatory protein 1-alpha, PAT 464.1, SCYA 3, SIS alpha, SIS-beta, Small-inducible cytokine A3, Tonsillar lymphocyte LD78 alpha protein, macrophage inflammatory protein 1a, small inducible cytokine A3 (homologous to mouse Mip-1a)

1 Images
Sanger Sequencing - Human CCL3 (Macrophage Inflammatory Protein 1) knockout THP-1 cell lysate (AB275506)
  • Sanger seq

Lab

Sanger Sequencing - Human CCL3 (Macrophage Inflammatory Protein 1) knockout THP-1 cell lysate (AB275506)

Allele-1 : 61 bp deletion in exon 1

Key facts

Cell type

THP-1

Species or organism

Human

Tissue

Blood

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 61 bp deletion in exon 1

Disease

Acute Monocytic Leukemia

style
left-column

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

Treatments:
Human CCL3 knockout THP-1 cell lysate - Brefeldin A (5 μg/ml, 6h)
Human wild-type THP-1 cell lysate - Brefeldin A (5 μg/ml, 6h)
Human CCL3 knockout THP-1 cell lysate - PMA (100 ng/ml, 56h), LPS (1 μg/ml, 24h) and Brefeldin A (5 μg/ml, during the last 6hr of LPS treatment)
Human wild-type THP-1 cell lysate - PMA (56h, 100 ng/ml), LPS (24h, 1 μg/ml) and Brefeldin A (5 μg/ml, during the last 6hr of LPS treatment)

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

style
left-column

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab275506-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human CCL3 knockout THP-1 cell lysate - Brefeldin A treated", "number":"AB275506-CMP03", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type THP-1 cell lysate - Brefeldin A treated", "number":"AB275506-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human CCL3 knockout THP-1 cell lysate - PMA, LPS + Brefeldin A treated", "number":"AB275506-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type THP-1 cell lysate - PMA, LPS and Brefeldin A treated", "number":"AB275506-CMP04", "productcode":"" } ] } } }
style
left-column

Properties and storage information

Gene name
CCL3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MIP-1 alpha also known as CCL3 is a chemokine that plays a critical role in the immune system. With a molecular weight of around 8 kDa it is primarily expressed in activated T-cells macrophages and fibroblasts. MIP-1 alpha acts as a signaling protein that binds to receptors on target cells directing the movement of immune cells. Researchers commonly refer to it using various alternative names such as MIP-1a and CCL3-alpha rat and it is frequently measured using assays like MIP-1 alpha ELISA for experimental analyses.
Biological function summary

Proteins including MIP-1 alpha participate in the recruitment and activation of diverse immune cells aiding the inflammatory response. Through interaction with receptors like CCR1 and CCR5 MIP-1 alpha mobilizes cells like natural killer cells and monocytes. This chemokine does not generally form part of a larger protein complex but interacts directly with membrane receptors to exert its function in immune cell chemotaxis.

Pathways

MIP-1 alpha operates in the context of both the inflammatory response and the chemokine signaling pathways. Its involvement in these pathways helps mediate the trafficking of leukocytes. Notably MIP-1 alpha interacts with proteins such as CCR1 and CCR5 to transmit signals that instigate immune responses. These proteins are integral to its role in modulating immunity providing targets for research into controlling inflammatory processes.

MIP-1 alpha closely relates to conditions such as rheumatoid arthritis and HIV infection. In rheumatoid arthritis its overexpression can lead to excessive inflammation and joint destruction. Meanwhile in HIV infection MIP-1 alpha interacts with CCR5 a co-receptor necessary for the virus entry into cells. This dual relationship elucidates its potential as a therapeutic target in managing both inflammatory diseases and viral entry mechanisms.
style
left-column

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

style
left-column

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Suspension

Gender

Male

style
left-column

Product protocols

style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB242545

Anti-MIP-1 alpha/CCL3 + CCL4/MIP-1 beta antibody [EPR19900-275] - BSA and Azide free (Capture)

RabMAb|Recombinant

Sandwich ELISA - Anti-MIP-1 alpha/CCL3 + CCL4/MIP-1 beta antibody [EPR19900-275] - BSA and Azide free (Capture) (AB242545)

  • 0
  • 0
Proteins & Peptides

AB283442

Recombinant Human MIP-1 alpha/CCL3 protein (Active)

Premium Bioactive

Biological Activity - Recombinant Human MIP-1 alpha/CCL3 protein (Active) (AB283442)

  • 0
  • 0
Assay Kits

AB200017

Mouse MIP-1 alpha/CCL3 ELISA Kit

SimpleStep

Sandwich ELISA - Mouse MIP-1 alpha/CCL3 ELISA Kit (AB200017)

  • 3
  • 1
Cell Lines & Lysates

AB273760

Human CCL3 (Macrophage Inflammatory Protein 1) knockout THP-1 cell line

Sanger Sequencing - Human CCL3 (Macrophage Inflammatory Protein 1) knockout THP-1 cell line (AB273760)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com